Antimicrobial multiresistance of Shigella sp strains in a semi rural community of north Santiago;Multirresistencia antimicrobiana en cepas de Shigella sp en una comuna semi rural del área norte de Santiago

Revista Medica de Chile

Volumn 126, Issue 12, 1998, Pages 1464-1471

  Prado, Valeria J ^a   Pidal, Paola M ^a   Arellano, Carolina C ^a   Lagos, Rosanna Z ^a   San Martin, Oriana B ^a   Levine, Myron M ^a  

^a Condell 303 Providencia ^*

Author keywords

Drug resistance, microbial; Microbial sensitivity tests; Shigella

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; CHILE; CLASSIFICATION; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PRESCHOOL CHILD; RURAL POPULATION; SHIGELLA; SHIGELLOSIS;

CHILD, PRESCHOOL; CHILE; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DYSENTERY, BACILLARY; HUMANS; MICROBIAL SENSITIVITY TESTS; RURAL POPULATION; SHIGELLA;

EID: 0032242242     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. FERRECCIO C, PRADO V, OJEDA A, CAYYAZO M, ABREGO P, GUERS L, LEVINE M. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am J Epidemiol 1991; 134: 614-27.
2. PRADO V, O'RYAN M, Acute gastroenteritis in Latin America. Infectious Disease Clinics of North American 1994; 8: 77-106.
3. HAIDER K, MALEK M, ALBERT M. Oceurence of drug resistance in Shigella species isolated from patients with diarrhoea in Bangladesh. J Antimicrob Chemother 1993; 32: 509-11.
4. LOLEKHA S, VIBULBANDHITKIT S. Response to antimicrobial therapy for Shigellosis in Thailand. Rev Infect Dis 1991; 13 (suppl 4): S342-6.
5. KAGALWALLA A, KHAN S, KAGALWALLA Y, ALOLA S, YAISU H. Chidhood Shigellosis in Saudi Arabia. Pediatr Infect Dis J 1992; 11: 215-9.
6. TOWNES J, QUICK R, GONZALES O, LINARES M, DAMIANI E, BOPP C, ET AL. Etiology of bloody diarrhea in Bolivian children: Implications for empiric therapy. J Infect Dis 1997; 175: 1527-30.
7. FINKELMAN Y, YAGUPSKY P, FRASER D, DAGAN R. Epidemiology of Shigella infections in two ethnic groups in a geographic region in southern Israel. Eur J Clin Microbiol Infect Dis 1994; 13: 367-73.
8. BENNISH M, WOJTYNIAK B. Mortality due to Shigellosis: Community and hospital data. Rev Infect Dis 1991; 13(suppl 4): S245-51.
9. LITWIN C, LEONARD R, CARROLL K, DRUMMOND W, PAVIA A. Characterization of endemic stains of Shigella sonnei by use of plasmid DNA analysis and pulsed-field gel electrophoresis to detect patterns of transmission. J Infect Dis 1997; 175: 864-70.
10. BRATOEVA M, JOHN J. Dissemination of trimethopim-resistant clones of Shigella sonnei in Bulgaria. J Infect Dis 1989; 159: 648-53.
11. RICHARD D, NOUSIA-ARVANITAKIS S, SOLLICH V, ET AL Oral ciprofloxacin is Intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic fibrosis study group. Pediatr Infect Dis J 1997; 16: 572-8.
12. SALAM M, BENNISH M. Antimicrobial Therapy for Shigellosis. Rev Infect Dis 1991; 13 (Suppl 4): S332-41.
13. BENNISH M. Potentially lethal complications of Shigellosis. Rev Infect Dis 1991; 13(suppl 4): S319-24.
14. BENNISH M, SALAM M, HOSSAIN M, MYAUX, HUQ KHAN E, CHAKRABORTY J ET AL. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: Increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clinical Infections Diseases 1992; 14: 1055-60.
15. EKO F, UTSALO S. Antimicrobial resistance trends of Shigella isolates from Calabar, Nigeria. J Trop Med Hyg 1991; 94: 407-10.
16. MATERU S, LEMA O, MAKUNZA H, ADHIAMBO C, CARTER J. Antibiotic resistance pattern of Vibrio cholerae and Shigella causing diarrhoea outbreaks in the eastern Africa region: 1994-1996. East Afr Med J 1997; 74: 193-7.
17. MACHE A, MENGISTU Y, COWLEY S. Shigella serogroups identified from adult diarrhoeal outpatients in Addis Ababa, Ethiopia: antibiotic resistance and plasmid profile analysis. East Afr Med 1997; 74: 179-82.
18. KUBIN R. Safety and efficacy of ciprofloxacin in paediatric patient-review. Infection 1993; 21: 413-21.
19. HARNETT N. High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada-an update. Epidemiol Infect 1992; 109: 463-72.
20. LIMA A, LIMA N, PINHO M, BARROS E, TEIXEIRA M, MAKTINS M ET AL. High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphienicol and tetracycline isolated from patients with Shigellosis in Northeastern Brazil during period 1988 to 1993. Antimicrob Agents Chemother 1995; 39: 256-59.
21. SACK R, RAHMAN M, YUNUS M, KHAN E. Antimicrobial resistance in organisms causing diarrheal disease. Clinical Infectious Diseases. 1997; 24 (Suppl 1): S102-5.
22. D'OTTONE: K, ASTORGA J, ZAPATA L, SEOANE M. Susceptibilidad antimicrobiana de 561 cepas de Shigella oblenidas de muestras clinicas. Rev Chil Infect 1985; 2: 57-60.
23. SIRI M, SANTOLAYA M, CÓRDOVA M, TORRES T. Sensibilidad in vitro de Shigella y correlación clínica después de la administración de cotrimoxazol oral. Rev Chil Infect 1982; 2: 106-8.
24. SALAM M, BENNISH M. Therapy for Shigellosis I. Randomized, double blind trial of nalidixic acid in childhood Shigellosis. J Pedieitr 1988; 113: 901-7.
25. ARMAN D, WILLKE A, TURAL D. In vitro activity of eight antibiotics against Salmonella and Shigella species. Eur J Epidemiol 1994; 10: 345-7.
26. LING J, KAM K, LAM A, FRENCH G. Susceptibilities of Hong Kong isolates of multiply resistant Shigella sp to 25 antimicrobial agents, including ampicillim plus sulbactam and new 4-quinolones. Antimicrob Agents Chemother 1988; 32: 2-23.
27. BENNISH M, SALAM M, HAIDEU R, BARZA M. Therapy for Shigellosis II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. J Infect 1990; 162: 711-16.
28. GOTTUZZO E, OBERHELMAN R, MAGUIÑA C, BERRY S, YI A, GUZMAN M ET AL. Comparison of singledose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulflamethoxazole for acute Shigellosis in adults. Antimicrob Agents Chemother 1989; 33: 1101-4.
29. KHAN W, SEAS C, DHAR U, SALAM M, BENNISH M. Treatment of Shigellosis: V. Comparison of azithromycin and ciprofloxacin. Ann Intern Med 1997; 126: 697-703.
30. ASHKENAZI S, MAY ZAHAV M, SULKES J, ZILBERBERG R, SAMRA Z. Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob Agents Chemother 1995; 39: 819-23.
31. SALAM M, SEAS C, KHAN W, BENNISH M. Treatment of Shigellosis: IV. Cefixime is ineffective in Shigellosis in adults. Ann Intern Med 1995; 123: 505-8.
32. KABIR I, BUTLER T, KHANAM A. Comparative efficacies of single intravenous closes of ceftriaxone and ampicillin for Shigellosis in placebo-controlled trial. Antimicrob Agents Chemother 1986; 29: 645-8.
33. CARLSON J, THORNTON S, DUPONT H, WEST A, MATTHWEVSON J. Comparative in vitro activities of ten antimicrobial agents against enteropathogens. Antimicrob Agents Cheinother 1983; 24: 509-13.
34. DUTTA P, SETT A, SARKAR A, MITUA U, SAHA D, MANNA B ET AL. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial. Indian Pediatr 1995; 32: 13-9.
35. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS 1998. Performance standards for antimicrobial susceptibility testing; Eight informational supplement.